三部门联合发布《医疗广告认定指南》加强医疗广告监管

Core Viewpoint - The joint release of the "Medical Advertising Recognition Guidelines" by the State Administration for Market Regulation, the National Health Commission, and the National Administration of Traditional Chinese Medicine aims to provide clearer and more actionable guidance to combat illegal medical advertising [1][2]. Group 1: Regulatory Framework - The guidelines clarify the definition of "medical advertising" and strictly limit the entities allowed to publish such advertisements, stating that only legally established medical institutions can do so [1]. - The guidelines differentiate between "medical advertising," "medical information disclosure," and "health science popularization," providing operational rules to help regulators identify and address misleading advertising practices [1][2]. Group 2: Enforcement and Impact - In the first half of 2025, the national market regulatory authorities handled 1,666 cases of illegal medical advertising, with fines totaling 12.78 million yuan [2]. - The State Administration for Market Regulation has intensified its enforcement efforts in the advertising market, focusing on the internet and key livelihood sectors, which includes medical, pharmaceutical, and health food advertising [2].